HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered beta-2 adrenergic receptor gene expression in human clinical hypertension.

AbstractOBJECTIVES:
The beta-2 adrenergic receptor is involved in mediating vasodilatation via neurohumoral and sympathetic nervous system pathways. Alterations in beta-2 adrenergic receptor gene expression (mRNA transcription) may contribute to the hypertensive phenotype. Human gene expression in clinical phenotypes remains largely unexplored due to ethical constraints involved in obtaining human tissue. We devised a method to obtain normally discarded internal mammary artery tissue from coronary artery bypass graft patients. We then investigated differences in hypertensive and normotensive participants' beta-2 adrenergic receptor gene expression in this tissue.
METHODS:
We collected arterial tissue samples from 46 coronary artery bypass patients in a surgical setting. Using 41 of the samples, we performed TaqMan real-time polymerase chain reaction (RT-PCR) and used the delta delta cycle threshold (DeltaDeltaCt) relative quantitation method for determination of fold-differences in gene expression between normotensive and hypertensive participants. The beta-2 adrenergic receptor target was normalized to glyceraldehyde-phosphate dehydrogenase.
RESULTS:
Participants with hypertension had significantly less-expressed beta-2 adrenoceptor gene (2.76-fold, p<.05) compared to normotensive participants. After Bonferroni correction, gene expression did not differ by race, gender, type/dose of beta-blocker prescribed, positive family history of hypertension, or diagnosis of diabetes mellitus type 2.
CONCLUSIONS:
These data support the possibility of a molecular basis for impaired adrenoceptor-mediated vascular tone in hypertension. Modification and extension of this research is required.
AuthorsJennifer R Dungan, Yvette P Conley, Taimour Y Langaee, Julie A Johnson, Shawn M Kneipp, Philip J Hess, Carolyn B Yucha
JournalBiological research for nursing (Biol Res Nurs) Vol. 11 Issue 1 Pg. 17-26 (Jul 2009) ISSN: 1099-8004 [Print] United States
PMID19254913 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Receptors, Adrenergic, beta-2
  • Glyceraldehyde-3-Phosphate Dehydrogenases
Topics
  • Case-Control Studies
  • Clinical Nursing Research
  • Coronary Artery Bypass
  • Effect Modifier, Epidemiologic
  • Female
  • Florida
  • Gene Expression (genetics)
  • Genetic Testing
  • Glyceraldehyde-3-Phosphate Dehydrogenases (genetics)
  • Humans
  • Hypertension (genetics)
  • Male
  • Mammary Arteries (cytology, transplantation)
  • Middle Aged
  • Multivariate Analysis
  • Phenotype
  • RNA, Messenger (genetics)
  • Receptors, Adrenergic, beta-2 (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction (methods)
  • Statistics, Nonparametric
  • Transcription, Genetic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: